| Identification | Back Directory | [Name]
Spiro[benzofuran-2(3H),1'-[2,5]cyclohexadiene]-2'-carboxylic acid, 5,7-dichloro-6'-methoxy-6-methyl-3,4'-dioxo-4-[[(1R,4R,5R,6S)-4,5,6-trihydroxy-2-(methoxycarbonyl)-2-cyclohexen-1-yl]oxy]-, methyl ester, (1'S)-rel-(+)- | [CAS]
196615-89-1 | [Synonyms]
Sch202596
Sch-202596
Sch 202596
Spiro[benzofuran-2(3H),1'-[2,5]cyclohexadiene]-2'-carboxylic acid, 5,7-dichloro-6'-methoxy-6-methyl-3,4'-dioxo-4-[[(1R,4R,5R,6S)-4,5,6-trihydroxy-2-(methoxycarbonyl)-2-cyclohexen-1-yl]oxy]-, methyl ester, (1'S)-rel-(+)- | [Molecular Formula]
C25H22Cl2O12 | [MOL File]
196615-89-1.mol | [Molecular Weight]
585.34 |
| Hazard Information | Back Directory | [Uses]
Sch 202596 is a non-peptide antagonist of the galanin receptor subtype GalR1. Sch 202596 blocks the action of galanin by binding to GalR1, thereby reducing food intake. Sch 202596 can be used in the study of obesity and related eating disorders[1]. | [References]
[1] Katoh T, et al. Studies toward the total synthesis of Sch 202596, an antagonist of the galanin receptor subtype GalR1: synthesis of geodin, the spirocoumaranone subunit of Sch 202596[J]. Tetrahedron Letters, 2000, 41(4): 465-469. |
|
|